1241533

Alejandro (NMI) Hoberman, M.D. — FEI 3006289355

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 18, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Pittsburgh, PA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
766621 CFR 50.20Understandable language